© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
All News
The Controversy Over Omega-3 Fatty Acids
A failed trial at the American Heart Association leads to pointed fingers at game-changing research on Vascepa, and counter claims of "manufactured controversy."
Is Inclisiran a PCSK9 Inhibitor?
April 16, 2021
In this third part of a three-part series, Steven D. Pearson, M.D., M.Sc., founder and president of ICER talks the drug Inclisiran and its relation to PCSK9 inhibitors.
Consumers Are Considering Prescription Changes and More Over High Drug Prices
April 16, 2021
A recent survey by Scripta Insights shows 96% of consumer are willing to make a prescription change as far as switching their medications, forms and where they fill in order to save money.
Whither the ACO?
April 16, 2021
The number of participants in the Medicare Shared Savings Program has tapered off, and the Direct Contracting Model may put accountable care organizations at a disadvantage. The National Association of ACOs wants the Biden CMS to make some changes.
The Impact PCSK9 Inhibitor Pricing had on Payers, ICER
April 15, 2021
In this second part of a three-part series, Steven D. Pearson, M.D., M.Sc., founder and president of ICER addresses if pricing of PCSK9 inhibitors put ICER on the map.
Using Predictive Analytics to Reduce Nurse Burnout
April 15, 2021
Burnout among nurses has been a major pain point for hospitals and health systems long before COVID. Nurses work long hours and face a unique combination of physical and emotional challenges, and a seemingly simple mistake can be fatal. As a result, burnout rates among nurses range from 15% to 45%, leading 1 in 3 nurses to leave the bedside within their first two years.
Migraine Treatment Awash in Choices
April 15, 2021
The triptans, long the workhorses of migraine treatment, have been joined by monoclonal antibodies and small-molecule drugs that block calcitonin gene-related peptide. What’s lacking is a precision approach to treatment based on biomarkers.
What Needs to be Done to Improve Interoperability Issues, Clinician Burden per David Lareau of Medicomp Systems
April 14, 2021
In this week’s episode of Tuning In to the C-Suite podcast Briana Contreras, associate editor of Managed Healthcare Executive, spoke with David Lareau, CEO of Medicomp Systems about four areas that must be addressed to improve the usability of health IT, address interoperability issues, and minimize clinician burden.
Pursuing the Holy Grail of Value-Based Care? Penn’s LDI Says Head This Way.
April 14, 2021
Whether the cup of value-based care is half empty or half full may depend on your point of view. But the grail certainly isn’t full. Some of the leading lights at the Leonard Davis Institute (LDI) of Health Economics at the University of Pennsylvania have released recommendations to hasten the volume-to-value healthcare transformation.
Amazon Continues to Step, Not Leap, Into Healthcare
April 13, 2021
A couple of years ago, there was a lot of chatter about the Amazonifcation of healthcare. Well, that hasn’t happened. But the company is breaking into a sector of the economy that accounts for almost 18% of the American gross domestic product. Perhaps healthcare’s journey of Amazonifcation has started but is going step by step.
A Faster Path to Medicare Coverage for Devices May Get Slower. Or Vanish Altogether
April 13, 2021
The Biden administration put a hold on the new and pending rule changes that the outgoing Trump administration made, so whether the Medicare Coverage of Innovative Technology pathway will ever take effect is uncertain. But many providers and payers — and presumably most device makers — are keeping a close watch on the fate of the pathway.